R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The intricacies of effectively transitioning active clinical...

European Union lawmakers designed EU Clinical Trial Regulation 536/2014 to heighten interest within the healthcare industry for planning and conducting clinical trials in the

R&D

JP Morgan Week 2025 - Day 1

On day 1 of JPM Week, join pharmaphorum as we hear about pharma's dealmaking plans and the changing pharma landscape.

R&D

Manufacturers can streamline and speed the batch release pro...

As of late November 2024, the US Food & Drug Administration had recorded 46 voluntary drug recalls in the United States during the year, down slightly from previous years – an indicatio

R&D

The role of bioanalysis as the foundation of precision medic...

Precision medicine, also known as personalised medicine, is transforming healthcare by providing tailored treatments to patients suffering from life-threatening conditions.

R&D

12 Questions with Peter Wickersham

Peter Wickersham is the Vice President and General Manager of Gilead Sciences UK & Ireland, and a leader in HIV treatment, liver disease, and oncology.

R&D